Platelet CKB as a potential contributor to serum creatine kinase abnormalities and metastasis in cancer patients.

Clin Exp Med · 2025 · PMC12605619 · PMID 41217562

Europe PMC DOI

hedged sentences

0.0740

closest p · 1.5× alpha

0.4400

boldest claim

The sentences

a nonsignificant trendP = 0.074so close (0.05 < p ≤ 0.1)

When modeled as a continuous predictor, CKII showed only a nonsignificant trend toward worse survival (HR per SD = 2.00, 95% CI 0.93–4.27, P = 0.074).

also in 5,406 other papers

did not reach statistical significanceP = 0.44not close (p > 0.1)

In the comparison across tumor stages, CK-BB levels were higher in stage IV patients; however, the difference did not reach statistical significance ( P = 0.44) (Fig. 4 E), possibly due to the limited sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.